Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure

Scandinavian Cardiovascular Journal

Volumn 43, Issue 5, 2009, Pages 324-329

  Zuber, Michel ^a   Cuculi, Florim ^a   Attenhofer Jost, Christine H ^b   Kipfer, Peter ^c   Buser, Peter ^d   Seifert, Burkhardt ^e   Erne, Paul ^a  

^a Department of Cardiology Kantonsspital Luzern ^*  (Switzerland)

^b KLINIK IM PARK   (Switzerland)

^c Outpatient Clinic for Cardiology   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

BNP; Chronic LV dysfunction; Cut off; Diagnostic accuracy; NT proBNP; Primary care setting

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; BIOLOGICAL MARKER; CARDIOVASCULAR AGENT; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIASTOLIC HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE; BLOOD; CHRONIC DISEASE; COMPLICATION; DYSPNEA; ECHOGRAPHY; EVALUATION STUDY; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; MIDDLE AGED; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SWITZERLAND; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; DYSPNEA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; ROC CURVE; SWITZERLAND; TREATMENT OUTCOME;

EID: 70350074786     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430902769919     Document Type: Article

References (20)

1. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial. J Am Coll Cardiol. 2003; 42:1793-800.
2. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study. Eur J Heart Fail. 2005;7:537-41.
3. Sim V, Hampton D, Phillips C, Lo SN, Vasishta S, Davies J, et al. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction- cost-effectiveness in relation to open access echocardiography. Fam Pract. 2003; 20:570-4.
4. Nielsen LS, Svanegaard J, Klitgaard NA, Egeblad H. Nterminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail. 2004;6:63-70.
5. Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract. 2006;56: 327-33.
6. McClure SJ, Caruana L, Davie AP, Goldthorp S, McMurray JJ. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ. 1998;317(7157):516-9.
7. Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: Cross-sectional study. BMJ. 2000;320 (7240):985-6.
8. Hetmanski DJ, Sparrow NJ, Curtis S, Cowley AJ. Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community. Heart. 2000;84:440-1.
9. Hill SA, Balion CM, Santaguida P, McQueen MJ, Ismaila AS, Reichert SM, et al. Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. Clin Biochem. 2007.
10. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40.
11. Gilman G, Nelson TA, Hansen WH, Khandheria BK, Ommen SR. Diastolic function: A sonographer's approach to the essential echocardiographic measurements of left ventricular diastolic function. J Am Soc Echocardiogr. 2007;20:199-209.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quanti- fication: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-63.
13. Mueller C, Laule-Kilian K, Scholer A, Nusbaumer C, Zeller T, Staub D, et al. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison. Kidney Int. 2005;67:278-84.
14. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP,Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594-600.
15. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly. 2007;137:4-12.
16. Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, Bachmann LM. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: Systematic review of test accuracy studies. Arch Intern Med. 2006;166:1073-80.
17. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-442.
18. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail. 2005;11(5 Suppl): S15-20.
19. Cuculi F, Walz B, Zuber M, Roos M, Erne P. Clinical correlates of very high brain natriuretic petpide values (In Print). Am Heart Hosp J. 2008;6:37-41.
20. Bursi F,Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-16.